• Mashup Score: 11

    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…

    Tweet Tweets with this article
    • Our conversation w/ @GIcancerDoc on #MOUNTAINEER: #Tucatinib + #Trastuzumab in Her2+ met #ColorectalCancer Full Int: - https://t.co/oT4KBpWayU - Also on “Oncology Brothers”🎙 #OncJC #MedTwitter #crcsm #OncEd @pashtoonkasi @VivekSubbiah @marklewismd @weldeiry #oncology #gism https://t.co/lPujwmnXx2

  • Mashup Score: 3

    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…

    Tweet Tweets with this article
    • @dradityabardia from @MGHCancerCenter walks us through #EMERALD study & how to incorporate this recent approval of #elacestrant in our clinical practice: Full Int: - https://t.co/0RucWrTCy4 - Also on the “Oncology Brothers” podcast #OncJC #MedTwitter #OncEd #bcsm @FDAOncology https://t.co/MlEkofaA8v

  • Mashup Score: 2

    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…

    Tweet Tweets with this article
    • To get the stage ready for upcoming GI @ASCO & to understand 1 of the most pivotal studies of 2022, we discuss #NICHE2 w/ @MyriamChalabi from @NKI_nl Full Int: - https://t.co/cjqS6TQbww - Also on “Oncology Brothers” podcast #OncJC #MedTwitter #OncEd #GISM #ChalabiPlot #GI23 https://t.co/5IOxHCjn9R